COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,193 Articles (22,713 medRxiv, 8,480 bioRxiv)

Most recent first Previous |  Page 836: Articles 8351-8360  | Next

Estimating the number of breakthrough COVID-19 deaths in the United States
Smith, J. P.
10.1101/2022.04.04.22272731 — Posted: 2022-04-04
Cardiac impairment in Long Covid 1-year post-SARS-CoV-2 infection
Roca-Fernandez, A., Wamil, M., Telford, A., Carapella, V., Borlotti, A., Monteiro, D., Thomaides-Brears, H., Kelly, M. D., Dennis, A., Banerjee, R., Robson, M., Brady, M., Lip, G., Bull, S., Heightman, M. J., Ntusi, N., Banerjee, A.
10.1101/2022.04.03.22272610 — Posted: 2022-04-04
Variation in National COVID-19 Mortality Rates Across Asian Subgroups in the United States, 2020
Xu, J. J.
10.1101/2022.04.02.22273341 — Posted: 2022-04-03
Does Metformin Decrease Mortality in Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19? A Multivariable and Propensity Score-adjusted Meta-analysis
Ma, Z., Krishnamurthy, M.
10.1101/2022.04.03.22273353 — Posted: 2022-04-03
Clinical and Economic Impact of Differential COVID-19 Vaccine Effectiveness in the United States
Maschio, M., Fust, K., Lee, A., Van de Velde, N., Buck, P. O., Kohli, M.
10.1101/2022.03.31.22272957 — Posted: 2022-04-03
Predictors of all-cause mortality among patients hospitalized with influenza, respiratory syncytial virus, or SARS-CoV-2
Hamilton, M. A., Liu, Y., Calzavara, A., Sundaram, M. E., Djebli, M., Darvin, D., Baral, S., Kustra, R., Kwong, J. C., Mishra, S.
10.1101/2022.03.31.22273111 — Posted: 2022-04-03
High rate of BA.1, BA.1.1 and BA.2 in triple vaccinated
Marking, U., Havervall, S., Greilert Norin, N., Christ, W., Gordon, M., Ng, H., Blom, K., Phillipson, M., Mangsbo, S., Smed-Sorensen, A., Nilsson, P., Hober, S., Aberg, M., Klingstrom, J., Thalin, C.
10.1101/2022.04.02.22273333 — Posted: 2022-04-03
Epidemiological topology data analysis links severe COVID-19 to RAAS andhyperlipidemia associated metabolic syndrome conditions
Platt, D. E., Bose, A., Levovitz, C., Rhrissorrakrai, K., PARIDA, L.
10.1101/2022.03.31.22273239 — Posted: 2022-04-03
Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature upon SARS-CoV-2 sensing by monocytes in COVID-19
Maher, A. K., Burnham, K. L., Jones, E., Baillon, L., Selck, C., Giang, N., Argüello, R. J., Short, C.-E., Quinlan, R., Barclay, W. S., Cooper, N., Taylor, G. P., Davenport, E. E., Dominguez-Villar, M.
10.1101/2022.04.03.486830 — Posted: 2022-04-03
Inferring the true number of SARS-CoV-2 infections in Japan
McKenzie, L., Shoukat, A., Wong, K. O., Itahashi, K., Yasuda, E., Demarsh, A., Khan, K.
10.1101/2022.04.01.22273214 — Posted: 2022-04-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).